Trial Profile
Controlled study of ONO-2506PO in patients with Parkinson's disease in Japan.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Oct 2012
Price :
$35
*
At a glance
- Drugs Arundic acid (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Ono Pharmaceutical
- 30 Sep 2006 New trial record.